
Keywords: HCC; hepatocellular carcinoma; NAFLD; non-alcoholic fatty liver disease; IMS; imaging mass spectrometry; MALDI; matrix-assisted laser desorption/ionization; LPCAT; lysophosphatidylcholine acyltransferase; PCA; principal component analysis; cPLA2α; cytoso